Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
10.80
-0.56 (-4.93%)
At close: Apr 28, 2026, 4:00 PM EDT
10.80
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Elicio Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 12.81 | 11.33 | 11.9 | 5.63 | 7.54 | |
| Research & Development | 24.9 | 33.66 | 23.85 | 18.1 | 17.93 | |
| Operating Expenses | 37.71 | 44.99 | 35.75 | 23.73 | 25.47 | |
| Operating Income | -37.71 | -44.99 | -35.75 | -23.73 | -25.47 | |
| Interest Expense | -1.13 | -0.46 | -1.06 | -3.6 | -0.88 | |
| Interest & Investment Income | 0.78 | 0.78 | 0.37 | 0.07 | 0 | |
| Currency Exchange Gain (Loss) | - | 0.15 | 0.2 | - | - | |
| Other Non Operating Income (Expenses) | -1.92 | -7.39 | 0.43 | -0.95 | -0.05 | |
| EBT Excluding Unusual Items | -39.99 | -51.9 | -35.8 | -28.21 | -26.4 | |
| Gain (Loss) on Sale of Assets | - | 0 | - | - | - | |
| Other Unusual Items | 0.42 | - | 0.61 | 0 | - | |
| Pretax Income | -39.57 | -51.9 | -35.2 | -28.21 | -26.4 | |
| Net Income | -39.57 | -51.9 | -35.2 | -28.21 | -26.4 | |
| Net Income to Common | -39.57 | -51.9 | -35.2 | -28.21 | -26.4 | |
| Shares Outstanding (Basic) | 15 | 12 | 5 | 0 | 15 | |
| Shares Outstanding (Diluted) | 15 | 12 | 5 | 0 | 15 | |
| Shares Change (YoY) | 25.48% | 141.35% | 1500.08% | -97.93% | 42.39% | |
| EPS (Basic) | -2.58 | -4.25 | -6.96 | -89.27 | -1.73 | |
| EPS (Diluted) | -2.58 | -4.25 | -6.96 | -89.27 | -1.73 | |
| Free Cash Flow | -36.97 | -37.16 | -32.76 | -22.83 | -24.46 | |
| Free Cash Flow Per Share | -2.41 | -3.04 | -6.48 | -72.26 | -1.60 | |
| EBITDA | -37.51 | -44.67 | -35.36 | -23.34 | -25.22 | |
| D&A For EBITDA | 0.2 | 0.32 | 0.38 | 0.39 | 0.25 | |
| EBIT | -37.71 | -44.99 | -35.75 | -23.73 | -25.47 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.